Trends: IND/CTA Align, Trop‑2 Combos, RWE in HTN/DM & Asthma eConsent
Five regulatory and design trends — from harmonizing IND/CTA in oncology to Trop-2 combos, RWE for HTN/DM, and asthma eConsent — explained in clear, actionable terms for sponsors, clinicians, and families.
Robert Maxwell
Oct 01, 2025
breast cancer biomarkers
Trop2 targeted therapy
psoriatic arthritis biologics
Diabetes device regulation